Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MSUD EASY
- Development stage
- Unknown
- Lead developer
- POA Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
MSUD EASY is a leucine, isoleucine, and valine-free protein substitute in tablet form, developed by POA Pharma Scandinavia for the dietary management of Maple Syrup Urine Disease (MSUD). It is classified as a Food for Special Medical Purposes (FSMP) and is designed for individuals who require a restricted intake of branched-chain amino acids (BCAAs) while maintaining adequate protein and micronutrient intake. The product provides a convenient alternative to traditional powdered amino acid formulas, which can improve patient compliance and quality of life. By providing a balanced mixture of essential and non-essential amino acids (excluding BCAAs), vitamins, and minerals, MSUD EASY helps prevent the toxic accumulation of leucine and its metabolites, which are characteristic of MSUD, while supporting normal growth and metabolic function.
- Brand names
- MSUD EASYMSUD EASY Tablets
- Other names
- MSUD EASY-POA Pharma Scandinavia-oral
Beyond the preview
Go deeper on MSUD EASY.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MSUD EASY.